Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
265.31
-2.26 (-0.84%)
Streaming Delayed Price
Updated: 3:27 PM EDT, Sep 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Reasons Johnson & Johnson Is Still a Buy With Its Stock Near a Record High
↗
Today 15:20 EDT
This is not an exhaustive list.
Via
The Motley Fool
Topics
Intellectual Property
3 Healthcare Dividend Stocks Offering More Than Just Income
↗
Today 11:35 EDT
AbbVie, Johnson & Johnson and Merck offer growing dividends alongside healthcare pipeline catalysts, regulatory approvals and rising analyst price targets heading into 2027.
Via
MarketBeat
SCHD's Top Sector Bet Is Healthcare at 20.7%. I'm Not Sure What's More Surprising: What It Doesn't Hold, or What It Does.
↗
Today 6:50 EDT
SHCD is missing some of the healthiest dividend stocks.
Via
The Motley Fool
Topics
ETFs
Stocks
Which dow jones stocks are moving on Tuesday?
↗
September 29, 2026
Via
Chartmill
Uncover the latest developments among dow jones stocks in today's session.
↗
September 29, 2026
Via
Chartmill
Top dow jones movers in Monday's session
↗
September 28, 2026
Via
Chartmill
Uncover the latest developments among dow jones stocks in today's session.
↗
September 28, 2026
Via
Chartmill
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 25, 2026
AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Friday's session: top gainers and losers in the dow jones index
↗
September 25, 2026
Via
Chartmill
Stay informed with the top movers within the dow jones index on Thursday.
↗
September 24, 2026
Via
Chartmill
Thursday's session: top gainers and losers in the dow jones index
↗
September 24, 2026
Via
Chartmill
Bear Markets May Feel Frightening, But Here's How You Can Come Out Ahead
↗
September 24, 2026
The next bear market may be your best opportunity to grow your portfolio.
Via
The Motley Fool
Topics
Economy
Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient Now?
↗
September 24, 2026
Bristol Myers Squibb trades at a steep valuation discount, while Johnson & Johnson's stronger margins and lower debt offer stability. But patent cliffs and litigation risks complicate both cases.
Via
The Motley Fool
Topics
Intellectual Property
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting?
↗
September 24, 2026
Wall Street thinks that this robotic surgical systems leader's sell-off is overdone.
Via
The Motley Fool
Topics
Earnings
2 Stocks to Buy Hand Over Fist if a Stock Market Crash Is Coming
↗
September 23, 2026
You can take these companies' dividends straight to the bank.
Via
The Motley Fool
Topics
Economy
DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026
September 22, 2026
From
DePuy Synthes
Via
Business Wire
Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal
↗
September 21, 2026
Healthcare giant Johnson & Johnson is looking to become a more profitable and faster-growing business.
Via
The Motley Fool
The Investing Playbook for Retirees Who Can't Afford to Lose
↗
September 21, 2026
It may not be possible to avoid all risks, but it's certainly possible to minimize them.
Via
The Motley Fool
Topics
Economy
Retirement
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down
↗
September 20, 2026
The unlocking of SpaceX shares is reshaping the communications sector.
Via
The Motley Fool
Topics
ETFs
These dow jones stocks are moving in today's session
↗
September 18, 2026
Via
Chartmill
Which dow jones stocks are moving on Friday?
↗
September 18, 2026
Via
Chartmill
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue?
↗
September 17, 2026
One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money.
Via
The Motley Fool
Johnson & Johnson Sees Path to Double-Digit Growth Despite 2026 Patent Cliff
↗
September 17, 2026
Johnson & Johnson (NYSE:JNJ) Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its...
Via
MarketBeat
Topics
Intellectual Property
The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
↗
September 17, 2026
As Fed and inflation worries mount, Casey's General Stores, Johnson & Johnson, and PepsiCo stand out as defensive dividend payers with healthy balance sheets, growing payouts, and buyback programs.
Via
MarketBeat
Topics
Economy
Uncover the latest developments among dow jones stocks in today's session.
↗
September 16, 2026
Via
Chartmill
Is AbbVie the Best Dividend King to Buy in September?
↗
September 16, 2026
It is certainly a good Dividend King to buy in September.
Via
The Motley Fool
Topics
Intellectual Property
My Top 5 Favorite Stocks for an Uncertain Market
↗
September 16, 2026
These players offer a certain level of stability in any market environment.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Intellectual Property
Discover which dow jones stocks are making waves on Tuesday.
↗
September 15, 2026
Via
Chartmill
3 Healthcare Stocks for 3 Stages of Life
↗
September 15, 2026
Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.
Via
MarketBeat
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition
↗
September 14, 2026
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline...
Via
MarketBeat
Topics
ETFs
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today